The Euphorbiaceae are notable for floral diversity and evolutionary complexity. Croton is the second largest genus in the family and exhibits particular diversity in its flowers. The aim of this study was to investigate the floral ontogeny and structure of three Croton species with distinct morphologies, with a focus on testing the hypothesis that the filaments of female flowers, which have received different interpretations in the literature and are currently described as reduced petals, are staminodes and part of a vestigial androecium. With the ontogenetic study we can understand the origin of the organs and associate these with flower evolution in the genus. Flowers in several stages of development were analysed using light microscopy and scanning electron microscopy. In the early stage of development, the sepals are the first structures to be formed, although they do not continue to grow in female Croton fuscescens Spreng. flowers. Petals are absent in female flowers, with filamentous, petaloid structures, interpreted here as staminodes, alternating with the sepals in Croton lundianus (Didr.) Müll. Arg. In Croton sphaerogynus Baill., the staminodes are located between the nectary lobes. The stamens exhibit centripetal development in the flower bud stage, and the carpels are post-genitally connate, with differences in style branching. Besides the ontogenetic interpretation for the filamentous structures, the genus shows transitional structures that we consider evolutionary reductions. Our results can explain how developmental alterations have influenced the suppression and modification of floral organs in the genus.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.